Epigenetic modification of DRG neuronal gene expression subsequent to nerve injury: Etiological contribution to complex regional pain syndromes (Part I)
暂无分享,去创建一个
[1] A. Armendariz,et al. Sex differences in formalin‐evoked primary afferent release of substance P , 2014, European journal of pain.
[2] R. Watts,et al. Nerve growth factor acts through the TrkA receptor to protect sensory neurons from the damaging effects of the HIV-1 viral protein, Vpr , 2013, Neuroscience.
[3] T. Graven-Nielsen,et al. Repeated intramuscular injections of nerve growth factor induced progressive muscle hyperalgesia, facilitated temporal summation, and expanded pain areas , 2013, PAIN®.
[4] F. Flores-Murrieta,et al. Role of hydrogen sulfide in the pain processing of non-diabetic and diabetic rats , 2013, Neuroscience.
[5] Yu Sun,et al. Macrophage migration inhibitory factor counter‐regulates dexamethasone‐induced annexin 1 expression and influences the release of eicosanoids in murine macrophages , 2013, Immunology.
[6] T. Hökfelt,et al. Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and the spinal cord of mice – Effects of peripheral axotomy or hindpaw inflammation , 2013, Neuroscience.
[7] R. Rodríguez,et al. Substance P mRNA expression during zebrafish development: influence of mu opioid receptor and cocaine , 2013, Neuroscience.
[8] M. Shakibaei,et al. Reduced number, G protein coupling, and antinociceptive efficacy of spinal mu-opioid receptors in diabetic rats are reversed by nerve growth factor. , 2013, The journal of pain : official journal of the American Pain Society.
[9] C. Chang,et al. Preemptive Low-dose Dexamethasone Reduces Postoperative Emesis and Pain After TKA: A Randomized Controlled Study , 2013, Clinical orthopaedics and related research.
[10] N. Morioka,et al. Volume transmission of substance P in striatum induced by intraplantar formalin injection attenuates nociceptive responses via activation of the neurokinin 1 receptor. , 2013, Journal of pharmacological sciences.
[11] D. Fischer,et al. Interleukin-6 contributes to CNS axon regeneration upon inflammatory stimulation , 2013, Cell Death and Disease.
[12] Gemma Gou,et al. Effects of treatment with a carbon monoxide-releasing molecule and a heme oxygenase 1 inducer in the antinociceptive effects of morphine in different models of acute and chronic pain in mice , 2013, Psychopharmacology.
[13] Jacques Noël,et al. Kv1.1 Channels Act as Mechanical Brake in the Senses of Touch and Pain , 2013, Neuron.
[14] Adelheid Lempradl,et al. Bridging epigenomics and complex disease: the basics , 2013, Cellular and Molecular Life Sciences.
[15] G. Strichartz,et al. Preventive Analgesia by Local Anesthetics: The Reduction of Postoperative Pain by Peripheral Nerve Blocks and Intravenous Drugs , 2013, Anesthesia and analgesia.
[16] Dongyang Huang,et al. The Role of Potassium Channel Activation in Celecoxib-Induced Analgesic Action , 2013, PloS one.
[17] F. Cidral-filho,et al. ST36 laser acupuncture reduces pain-related behavior in rats: involvement of the opioidergic and serotonergic systems , 2013, Lasers in Medical Science.
[18] A. Cuello,et al. Inhibition of endogenous NGF degradation induces mechanical allodynia and thermal hyperalgesia in rats , 2013, Molecular pain.
[19] Xingmei Feng,et al. Hydrogen sulfide increases excitability through suppression of sustained potassium channel currents of rat trigeminal ganglion neurons , 2013, Molecular pain.
[20] Johan Marinus,et al. Neurodegeneration and inflammation in MS , 2013, Neurology.
[21] S. McMahon,et al. Sensory Neuron Downregulation of the Kv9.1 Potassium Channel Subunit Mediates Neuropathic Pain following Nerve Injury , 2012, The Journal of Neuroscience.
[22] H. Yamanaka,et al. Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury , 2012, Glia.
[23] Jessica K. Alexander,et al. Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress , 2012, Experimental Neurology.
[24] T. Guo,et al. Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain , 2012, Journal of Neuroinflammation.
[25] A. Kawabata,et al. Hydrogen sulfide‐induced mechanical hyperalgesia and allodynia require activation of both Cav3.2 and TRPA1 channels in mice , 2012, British journal of pharmacology.
[26] M. A. Merrill,et al. Spinal nerve ligation decreases γ‐aminobutyric acidB receptors on specific populations of immunohistochemically identified neurons in L5 dorsal root ganglion of the rat , 2012, The Journal of comparative neurology.
[27] H. Noaman,et al. Surgical Treatment of Peripheral Nerve Injury , 2012 .
[28] A. Banožić,et al. Dorsal root ganglion – a potential new therapeutic target for neuropathic pain , 2012, Journal of pain research.
[29] M. Shin,et al. Identification of 5-HT receptor subtypes enhancing inhibitory transmission in the rat spinal dorsal horn in vitro , 2012, Molecular pain.
[30] Charles N. Serhan,et al. Resolving TRPV1- and TNF-α-Mediated Spinal Cord Synaptic Plasticity and Inflammatory Pain with Neuroprotectin D1 , 2011, The Journal of Neuroscience.
[31] M. Mata,et al. Vector‐mediated release of GABA attenuates pain‐related behaviors and reduces NaV1.7 in DRG neurons , 2011, European journal of pain.
[32] G. Burnstock,et al. Purinergic signalling: From normal behaviour to pathological brain function , 2011, Progress in Neurobiology.
[33] W. Guo,et al. Spinal 5-HT3 Receptor Activation Induces Behavioral Hypersensitivity via a Neuronal-Glial-Neuronal Signaling Cascade , 2011, The Journal of Neuroscience.
[34] V. Jevtovic-Todorovic,et al. T‐type voltage‐gated calcium channels as targets for the development of novel pain therapies , 2011, British journal of pharmacology.
[35] H. Steinbusch,et al. Role of TNF-alpha during central sensitization in preclinical studies , 2011, Neurological Sciences.
[36] 玉垣 伸二. Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn , 2011 .
[37] Jie Yang,et al. Spinal Macrophage Migration Inhibitory Factor Is a Major Contributor to Rodent Neuropathic Pain-like Hypersensitivity , 2011, Anesthesiology.
[38] L. Gerola,et al. Cytokines and pain. , 2011, Revista brasileira de anestesiologia.
[39] T. Takebayashi,et al. Does Norepinephrine Influence Pain Behavior Mediated by Dorsal Root Ganglia?: A Pilot Study , 2011, Clinical orthopaedics and related research.
[40] L. Audoly,et al. A novel role of prostaglandin E2 in neuropathic pain , 2011, Glia.
[41] P. Séguéla,et al. Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase C , 2011, Molecular pain.
[42] P. Holzer. Acid sensing by visceral afferent neurones , 2011, Acta physiologica.
[43] O. Pol,et al. Peripheral effects of morphine and expression of μ-opioid receptors in the dorsal root ganglia during neuropathic pain: nitric oxide signaling , 2011, Molecular pain.
[44] J. Gu,et al. Are voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain? , 2011, Molecular pain.
[45] Miguel Salinas,et al. Acid-sensing ion channels (ASICs): pharmacology and implication in pain. , 2010, Pharmacology & therapeutics.
[46] D. Martins,et al. High-intensity extended swimming exercise reduces pain-related behavior in mice: involvement of endogenous opioids and the serotonergic system. , 2010, The journal of pain : official journal of the American Pain Society.
[47] K. Keay,et al. Peripheral nerve injury differentially regulates dopaminergic pathways in the nucleus accumbens of rats with either ‘pain alone’ or ‘pain and disability’ , 2010, Neuroscience.
[48] C. Qu,et al. The role of dopamine receptors in ventrolateral orbital cortex-evoked anti-nociception in a rat model of neuropathic pain , 2010, Neuroscience.
[49] T. Yaguchi,et al. Noradrenaline stimulates ATP release from DRG neurons by targeting β3 adrenoceptors as a factor of neuropathic pain , 2010, Journal of cellular physiology.
[50] J. Ochoa,et al. A search for activation of C nociceptors by sympathetic fibers in complex regional pain syndrome , 2010, Clinical Neurophysiology.
[51] J. Ochoa,et al. Neuropathic pain syndrome displayed by malingerers. , 2010, The Journal of neuropsychiatry and clinical neurosciences.
[52] A. Ferrer-Montiel,et al. GABAA receptor associated protein (GABARAP) modulates TRPV1 expression and channel function and desensitization , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[53] C. Maihöfner,et al. Complex regional pain syndromes: new pathophysiological concepts and therapies , 2010, European journal of neurology.
[54] M. Barrot,et al. Chronic treatment with agonists of β2-adrenergic receptors in neuropathic pain , 2010, Experimental Neurology.
[55] E. Distrutti,et al. Hydrogen sulphide induces μ opioid receptor-dependent analgesia in a rodent model of visceral pain , 2010, Molecular pain.
[56] A. Patapoutian,et al. TRPV1 and TRPA1 Mediate Peripheral Nitric Oxide-Induced Nociception in Mice , 2009, PloS one.
[57] Heuiran Lee,et al. Effective neuropathic pain relief through sciatic nerve administration of GAD65-expressing rAAV2. , 2009, Biochemical and biophysical research communications.
[58] Martin Schmelz,et al. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I , 2009, PAIN®.
[59] M. Freire,et al. Pain Modulation by Nitric Oxide in the Spinal Cord , 2009, Front. Neurosci..
[60] H. Fields,et al. Is reflex sympathetic dystrophy/complex regional pain syndrome type I a small‐fiber neuropathy? , 2009, Annals of neurology.
[61] K. Ren,et al. Role of interleukin-1β during pain and inflammation , 2009, Brain Research Reviews.
[62] J. Mogil. Animal models of pain: progress and challenges , 2009, Nature Reviews Neuroscience.
[63] L. Menescal-de-Oliveira,et al. Role of cholinergic, opioidergic and GABAergic neurotransmission of the dorsal hippocampus in the modulation of nociception in guinea pigs. , 2008, Life sciences.
[64] L. Descarries,et al. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion , 2008, Neuroscience.
[65] A. Pertovaara,et al. Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat , 2007, Experimental Neurology.
[66] W. Guo,et al. Glial–Cytokine–Neuronal Interactions Underlying the Mechanisms of Persistent Pain , 2007, The Journal of Neuroscience.
[67] Christian Rosenmund,et al. Vesicular Glutamate Transporter VGLUT2 Expression Levels Control Quantal Size and Neuropathic Pain , 2006, The Journal of Neuroscience.
[68] Z. Pan,et al. Contribution of brainstem GABAA synaptic transmission to morphine analgesic tolerance , 2006, PAIN.
[69] H. Takeshima,et al. The opioid peptide nociceptin/orphanin FQ mediates prostaglandin E2‐induced allodynia, tactile pain associated with nerve injury , 2006, The European journal of neuroscience.
[70] Y. de Koninck,et al. Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia. , 2005, Current topics in medicinal chemistry.
[71] L. Menescal-de-Oliveira,et al. Cholinergic-opioidergic interaction in the central amygdala induces antinociception in the guinea pig. , 2004, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[72] G. Devries,et al. Prostaglandin E2 and 6‐keto‐prostaglandin F1α production is elevated following traumatic injury to sciatic nerve † , 2004, Glia.
[73] M. Narita,et al. Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. , 2004, Life sciences.
[74] M. Davies,et al. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II , 2003, Pain.
[75] Atsushi Tokunaga,et al. Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats , 2003, Pain.
[76] C.Justin Lee,et al. Functional Expression of AMPA Receptors on Central Terminals of Rat Dorsal Root Ganglion Neurons and Presynaptic Inhibition of Glutamate Release , 2002, Neuron.
[77] Lan Bao,et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[78] J. Sato,et al. B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation. , 2001, Journal of neurophysiology.
[79] J. Campbell. Nerve lesions and the generation of pain , 2001, Muscle & nerve.
[80] C. Woolf,et al. Spared nerve injury: an animal model of persistent peripheral neuropathic pain , 2000, Pain.
[81] M. Satoh,et al. Possible involvement of descending serotonergic systems in antinociception by centrally administered elcatonin in mice. , 1999, Biological & pharmaceutical bulletin.
[82] C. G. Cardenas,et al. Serotonergic modulation of hyperpolarization‐activated current in acutely isolated rat dorsal root ganglion neurons , 1999, The Journal of physiology.
[83] E. Senba,et al. Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons. , 1999, Brain research. Molecular brain research.
[84] A. Basbaum,et al. NMDA-receptor regulation of substance P release from primary afferent nociceptors , 1997, Nature.
[85] S. Hassenbusch,et al. Reflex sympathetic dystrophy: changing concepts and taxonomy , 1995, Pain.
[86] B. Ault,et al. Activation of nociceptive reflexes by peripheral kainate receptors. , 1993, The Journal of pharmacology and experimental therapeutics.
[87] A. Dray,et al. Bradykinin and inflammatory pain , 1993, Trends in Neurosciences.
[88] L. D. van de Kar,et al. Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. , 1991, The Journal of pharmacology and experimental therapeutics.
[89] Fuzhou Wang,et al. Homeostatic Synaptic Plasticity: Balanced by COX2-PGE2 System to a New Setpoint□PC , 2013 .
[90] S. V. Padi,et al. Pharmacological activation of heme oxygenase (HO)-1/carbon monoxide pathway prevents the development of peripheral neuropathic pain in Wistar rats , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.
[91] S. Mitra,et al. Peripheral opioid receptor agonists for analgesia: a comprehensive review. , 2011, Journal of opioid management.
[92] P. Panula,et al. Histamine in neurotransmission and brain diseases. , 2010, Advances in experimental medicine and biology.
[93] L. Branco,et al. Antinociception synergy between the peripheral and spinal sites of the heme oxygenase-carbon monoxide pathway. , 2009, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[94] J. Scholz,et al. Interaction of morphine but not fentanyl with cerebral alpha2-adrenoceptors in alpha2-adrenoceptor knockout mice. , 2009, The Journal of pharmacy and pharmacology.
[95] Karamarie Fecho,et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. , 2007, Pain.
[96] M. Kesim,et al. Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain. , 2004, Journal of pharmacological sciences.